{
  "compound": "THC (5mg sublingual)",
  "condition": "GLAUCOMA",
  "effect_size": "Large (d = 0.94)",
  "study_type": "RCT",
  "source": "NORML:GLAUCOMA_RCT_001",
  "participants": "6 patients with open-angle glaucoma",
  "year": 2006,
  "notes": "Sublingual THC for Intraocular Pressure Reduction: Randomized Controlled Trial",
  "confidence": "medium",
  "abstract": "THC 5mg: 23% IOP reduction (p<0.01) at 2 hours; Duration: 3-4 hours; Clinically significant in all subjects"
}